OverviewChartNewsTraderScreen

Oragenics Inc/  US6840235005  /

IEX
10/3/2024  9:59:55 PM Chg. - Volume Bid- Ask- High Low
0.40USD - 600
Turnover: 240.48		 -Bid Size: - -Ask Size: - 0.40 0.40
GlobeNewswire 8/21 Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation ...
GlobeNewswire 8/16 Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYS...
GlobeNewswire 8/14 Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wid...
GlobeNewswire 8/12 Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
GlobeNewswire 8/8 Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity T...
GlobeNewswire 7/10 Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
GlobeNewswire 6/27 Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
GlobeNewswire 6/26 Oragenics, Inc. Announces Closing of Public Offering
GlobeNewswire 6/25 Oragenics, Inc. Announces Pricing of Public Offering
GlobeNewswire 6/25 Oragenics, Inc. Announces Proposed Public Offering
GlobeNewswire 6/20 Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
GlobeNewswire 5/22 Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer
GlobeNewswire 5/17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 5/16 Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire 5/7 Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
GlobeNewswire 9/1/2020 Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developm...
GlobeNewswire 7/14/2020 Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors
GlobeNewswire 4/30/2019 Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomer...
GlobeNewswire 6/20/2018 Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 P...
GlobeNewswire 5/16/2018 Oral Proteins and Peptides Market, 2030
GlobeNewswire 6/29/2017 Rocky Mountain High Brands Announces Jerry Grisaffi’s Retirement; Gerry David Named Chairman of the ...
GlobeNewswire 4/25/2017 Rocky Mountain High Brands Appoints Award Winning CEO, Gerry David, to Its Board of Directors and Sp...